TrialThe Journal of infectious diseases2019

A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection.

Lesia K Dropulic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.